Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPHIR: PQ912 in Early Alzheimer's Disease
NCT02389413Phase 2Completed
- Sponsor
- Vivoryon Therapeutics N.V.
- Start
- Mar 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of varoglutamstat in Alzheimer's disease (AD), sponsored by Vivoryon Therapeutics N.V.. Started Mar 2015; status: completed.
02
Drugs
varoglutamstat
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02389413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389413.